TrialArthritis & rheumatology (Hoboken, N.J.)2018

Belimumab for the Treatment of Early Diffuse Systemic Sclerosis: Results of a Randomized, Double-Blind, Placebo-Controlled, Pilot Trial.

Jessica K Gordon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.